Hans T. Schambye
Chief Executive Officer, Damora Therapeutics, Inc.
Companies
- Damora Therapeutics, Inc.Board member Oct 28, 2020 to now1
- Damora Therapeutics, Inc.Chief executive officer Oct 28, 2020 to Sep 28, 20261
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Damora Therapeutics, Inc. DMRA4,682 shares2$85.8K at $18.32Jan 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 2, 2026Sold 700 shares at $21.38 of Damora Therapeutics, Inc.2
- Jan 2, 2026Exercised options 1,360 shares of Damora Therapeutics, Inc.2
- Jul 3, 2025Sold 735 shares at $3.38 of Damora Therapeutics, Inc.3
- Jul 3, 2025Exercised options 1,360 shares of Damora Therapeutics, Inc.3
- Jan 3, 2025Sold 1,341 shares at $5.60 of Damora Therapeutics, Inc.4
- Jan 3, 2025Exercised options 2,640 shares of Damora Therapeutics, Inc.4
- Mar 22, 2022Bought 5,000 shares at $2.15 of Damora Therapeutics, Inc.5
- Nov 9, 2021Bought 4,500 shares at $3.50 of Damora Therapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jul 8, 2025
- 4SEC EDGARForm 4 filed Jan 7, 2025
- 5SEC EDGARForm 4 filed Mar 23, 2022
- 6SEC EDGARForm 4 filed Nov 10, 2021